Regenerative medicine is one of the most fascinating fields in medical science. ISSCA is opening two new education centers in order to keep promoting excellence in the field of regenerative medicine.

The International Society for Stem Cells Applications (ISSCA) is set to open two Regenerative Medicine education centers in Tunisia and Belgium.

With this new development, ISSCA is significantly achieving its objective of bringing together as members and professionals of the science for productive collaborations around the Stem Cell research in all its possible fields. ISSCA has created a platform for physicians to collaborate actively, initiate discussions, share comment and exchange information that may be directly translated to therapeutic applications.

ISSCA’s Stem cells and Regenerative Medicine course provides competency training and certification to allied health professionals involved in the practice of Regenerative Medicine. The courses are designed to sequentially build a knowledge foundation to allow physicians to understand and verbalize basic and advanced scientific concepts pertaining to all aspects of Regenerative Medicine.

ISSCA believes the realm of regenerative medicine offers physicians and patients the most exciting frontier in medicine today, and they strive to make it available to them. Physicians should take ISSCA certification because it offers the advantage of world-class research with the endorsement of prestigious medical schools and clinical enterprise. ISSCA offers physicians the opportunity to learn about new, up to date technologies that are applicable to modern therapeutic approaches like stem cell applications.

As a medical specialty, regenerative medicine standards and certifications are essential; which is why ISSCA offers certification training in cities all over the world. ISSCA physicians learn the skills they need to implement regenerative medicine protocols in their practice. Once the participant completes all the units successfully, he/she receives a certificate of training.

About ISSCA:

The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.  

ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine.  Their code of ethics emphasizes principles of morals and ethical conducts.

At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative

medicine and make it available to benefit patients both nationally and globally.

For more information, please visit: https://www.issca.us/ or send an email to infor@stemcellsgroup.com  

MIAMI,  Dec. 4, 2018—The International Society for Stem Cell Application (ISSCA) has released its 2019 regenerative medicine certification training course calendar, with programs scheduled in seven international cities and updated curriculum. ISSCA’s objective in 2019 is to provide enhanced educational qualifications to physicians looking for a new approach to treat patients suffering with chronic pain, severe injury, and degenerative conditions and diseases.

The two-day regenerative medicine training course, which teaches easy-to-follow protocols for harvesting adipose and bone marrow stem cells from patients in a clinical environment, will also feature new treatment basics involving allogeneic compounds including exosomes and  other compounds derived from (umbilical) cord blood and amniotic fluid, allowing participating physicians to easily and efficiently add certification in cutting-edge regenerative medicine therapies to their practices.

Participating physicians learn how to harvest and isolate bone marrow and adipose-derived autologous stem cells to use in treating multiple conditions.

The two-day course begins with a four-hour lecture on advances in regenerative medicine. Participating physicians will receive more than 12 hours of hands-on training with live patients in protocols for obtaining stem cells from patients, applications that they can take back to their medical offices or clinics and begin using immediately.  

Attendees will also receive 12 protocols in digital format to take with them, and gain knowledge and practical skills to easily add regenerative medicine therapies to their practices.

Physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets and more.

The 2019 ISSCA training course calendar is as follows:

January 18-19, 2019  Miami, Fla. (conducted in Spanish language).

http://cursocelulasmadre.com/entrenamiento-miami-mail/ January 25.26, 2019  Miami, Fla. (Conducted in English language). https://www.stemcelltraining.net/miami-stem-cells-course-adwords/

February 1-2, 2019  Quito, Ecuador

February 8-9, 2019  Buenos Aires, Argentina

February 15-16, 2019, Lima, Peru

Fenruary 22-23, 2019  Bogota, Colombia

March 1-2, 2019  Mexico City, Mexico

https://cursocelulasmadre.com/entrenamiento-cancun-mail/ – needs to be fixed – links to a December date!

March 8-9  Abu Dabhi, UAE  

https://www.stemcelltraining.net  – not a good link! Please correct

ISSA’s stem cell certification course offers practical, personalized training in stem cell harvesting and isolation procedures. To date, ISSCA has trained more than 2,000 physicians worldwide.

Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.

To learn more about the ISSCA certification training courses and to register to participate, visit the Stem Cells Training website, the email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.   

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

MIAMI, Dec. 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host its sixth annual “Applications of Cell Therapies in Medicine and Aesthetic Surgery” regenerative medicine symposium in Buenos Aires, Argentina August 16-17, 2019. The focus of the symposium agenda will be allogeneic compounds—how they have changed the regenerative medicine industry, and how the industry will accommodate the challenges allogeneic therapies present.

The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research.

In 2018, the  5th annual symposium was held in three international cities—Buenos Aires, Istanbul, Turkey and Caracas, Venezuela. Each event exceeded organizers’ expectations both in attendance numbers and active participation. More than 200 physicians from the U.S., South America, Europe, the Middle East and Asia  attended the symposiums in Istanbul and Caracas, and more than 350 physicians from around the world attended in Buenos Aires. 

 The high attendance and enthusiastic participation of attendees at the Argentina symposium, which was held at the Universidad de Buenos Aires, compelled ISSCA organizers to reconsider their multi-country strategy and host the event exclusively in  Buenos Aires in 2019. In addition, ISSCA has committed to hosting the annual symposium in Buenos Aires for the next six consecutive years.

In keeping with ISSCA’s commitment to supporting the most current advances in stem cell and regenerative medicine discoveries, the 2019 symposium will explore  the impact the acceleration of allogeneic compounds have had on the industry, new challenges they bring to the market, and promising new therapies they are expected to provide to an ever-widening spectrum of diseases and medical conditions.

A group of renowned international speakers, experts in the field of stem cell and regenerative medicine including the latest advances in allogeneic therapies, will lead rigorous scientific discussions and Q&A sessions with physicians in attendance. In Addition, ISSCA has invited representatives from  [name of’ lab?], one of the world’s largest regenerative medicine labs to share their experiences and knowledge with physicians representing the global medical community in attendance,

The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells and regenerative medicine solutions.. In addition, business opportunities, industry challenges, and potential strategies for overcoming those challenges will be discussed.

The event venue in Buenos Aires will be announced shortly.

To learn more about the ISSCA Buenos Aires symposium and to reserve a seat, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.